BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PharmaMar S.A. 

Pol Ind. la Mina Avenida de los Reyes, 1

Colmenar Viejo  Madrid  28770  Spain
Phone: 34-91-8466000 Fax: 34-91-8466001


SEARCH JOBS










 Company News
Myriad Genetics, Inc. (MYGN) Partners With PharmaMar S.A. for New HRD Test 3/29/2013 8:23:55 AM
Spanish Biotech PharmaMar S.A. Selects Medidata Solutions, Inc. Clinical Cloud to Accelerate Trials for Marine-Based Oncology Drugs 3/18/2013 10:07:36 AM
PharmaMar S.A. Commences Clinical Trial in U.S. with New Antitumor Product, PM060184 2/8/2011 8:14:33 AM
PharmaMar S.A. Initiates a Phase III Registration Trial with Aplidin(R) in Multiple Myeloma Patients 6/9/2010 10:06:36 AM
PharmaMar S.A. Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 4/22/2010 10:58:40 AM
Zeltia Group (18494051.MA)'s PharmaMar S.A. in Deal With US Medimetriks Pharmaceuticals, Inc. 6/10/2009 7:20:23 AM
Innovex (INVX) to Promote PharmaMar S.A.'s Yondelis(R) Cancer Treatment 12/3/2007 9:17:09 AM
Dr. Enrique Sendagorta Appointed Managing Director Of PharmaMar S.A. 1/22/2007 10:58:27 AM
PharmaMar S.A. Release: Successful Planned Independent Analysis Of Pivotal Phase III Trial Of YONDELIS® In Ovarian Cancer 10/6/2006 11:52:18 AM
PharmaMar S.A. Reports New Data On Kahalalide-F And Aplidin(R) At ESMO Congress 9/29/2006 4:12:55 PM
123